Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
ROBIN SHERRINGTON
EVP, Strategy & Innovation at Xenon Pharmaceuticals. Filing since 28 May 2021.
CIK 0001619962
Company
Date
Role
Action
Shares
Amount
Of holding
XENE
Xenon Pharmaceuticals Inc.
7 Mar 2024
EVP, Strategy & Innovation
Sold at will
7,137
$330.29K
45.9%
XENE
Xenon Pharmaceuticals Inc.
1 Sep 2022
EVP, Strategy & Innovation
Sold, plan not stated
43,879
$1.68M
72.3%
XENE
Xenon Pharmaceuticals Inc.
31 Aug 2022
EVP, Strategy & Innovation
Sold, plan not stated
21,352
$823.55K
56.0%
XENE
Xenon Pharmaceuticals Inc.
4 Mar 2022
EVP, Strategy & Innovation
Sold, plan not stated
21,710
$662.21K
55.7%
XENE
Xenon Pharmaceuticals Inc.
28 May 2021
EVP, Strategy & Innovation
Sold, plan not stated
6,067
$114.12K
15.8%
5 decisions on file.
